The US Food and Drug Administration has approved the use of the anti-obesity drug Wegovy to prevent serious heart conditions . Wegovy , produced by Novo Nordisk , is now approved to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight.
This decision could expand insurance coverage and benefit the majority of American adults who are obese or overweight.
FDA Anti-Obesity Drug Wegovy Heart Conditions Cardiovascular Disease Obesity Overweight Novo Nordisk Insurance Coverage
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: